Free Trial
Marie Thibault

Marie Thibault Analyst Performance

Managing Director at BTIG Research

Marie Thibault is a stock analyst at BTIG Research focused in the medical sector, covering 24 publicly traded companies. Over the past year, Marie Thibault has issued 8 stock ratings, including buy and hold recommendations. While full access to Marie Thibault's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Marie Thibault's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
62 Last 5 Years
Buy Recommendations
78.33% 47 Buy Ratings
Companies Covered
24 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy78.3%47 ratings
Hold21.7%13 ratings
Sell0.0%0 ratings

Out of 60 total stock ratings issued by Marie Thibault at BTIG Research, the majority (78.3%) have been Buy recommendations, followed by 21.7% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.0% of companies on NASDAQ
18 companies
NYSE
25.0% of companies on NYSE
6 companies

Marie Thibault, an analyst at BTIG Research, currently covers 24 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
23 companies
95.8%
Computer and Technology
1 company
4.2%

Marie Thibault of BTIG Research specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
6 companies
25.0%
SURGICAL & MEDICAL INSTRUMENTS
5 companies
20.8%
MED PRODUCTS
3 companies
12.5%
MEDICAL SERVICES
2 companies
8.3%
MEDICAL INFO SYS
2 companies
8.3%
ELECTROMEDICAL EQUIPMENT
2 companies
8.3%
MED - BIOMED/GENE
1 company
4.2%
HEALTH SERVICES
1 company
4.2%
COMP - SOFTWARE
1 company
4.2%
PROCESS CONTROL INSTRUMENTS
1 company
4.2%

About Marie Thibault

Marie Thibault is a Managing Director and BTIG Medical Technology and Digital Health Analyst. Prior to BTIG, Ms. Thibault was the Managing Editor of Medical Device & Diagnostics Industry, a trade publication covering medical technology. Earlier in her career, she was a Senior Associate within Medical Technology Equity Research at Lazard Capital Markets. Ms. Thibault earned a BS in biology with a minor in writing from the Massachusetts Institute of Technology and a master’s degree in business and economic reporting from New York University.
Follow on LinkedIn

Marie Thibault's Ratings History at BTIG Research

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Masimo Corporation stock logo
MASI
Masimo
9/11/2025Reiterated Rating$145.82$198.00Buy
Embecta Corp. stock logo
EMBC
Embecta
9/5/2025Reiterated Rating$14.96$25.00Buy
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
8/20/2025Reiterated Rating$2.55Neutral
Abbott Laboratories stock logo
ABT
Abbott Laboratories
7/18/2025Lower Price Target$120.76$145.00Buy
Outset Medical, Inc. stock logo
OM
Outset Medical
7/14/2025Set Price Target$19.77$37.00Buy
Masimo Corporation stock logo
MASI
Masimo
5/7/2025Set Price Target$150.11$193.00Buy
Boston Scientific Corporation stock logo
BSX
Boston Scientific
4/23/2025Reiterated Rating$99.01$124.00Buy
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
3/20/2025Initiated Coverage$4.43$12.00Buy